Document is current

Article History

Accepted: 3 July 2025

First Online: 17 July 2025

Declarations

:

: No external funding was used in the preparation of this article.

: Eva Ellebaek received honoraria for consultancies and lectures from Novartis, Merck, Bristol-Myers Squibb, and Pierre Fabre, as well as conference and travel coverage from Pierre Fabre and Merck. Troels Holz Borch has received speaker honoraria from Bristol Myers Squibb. Marco Donia has received advisory fees from Achilles Therapeutics, and consultancy fees via membership of Guidepoint LLC and the AlphaSights expert network. Inge Marie Svane received honoraria for consultancies and lectures from Novartis, Roche, Merck, and Bristol Myers Squibb; a restricted research grant from Novartis; and financial support for attending symposia from Bristol Myers Squibb, Merck, Novartis, Pfizer, and Roche. Cecilie Dam Vestergaard has no conflicts of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: No datasets were generated or analyzed during the current study.

: Not applicable.

: CDV: conceptualization, writing (original draft preparation) and project administration. EE, THB, MD: conceptualization, writing (reviewing and editing), and supervision. IMS: conceptualization, writing (reviewing and editing), supervision, and project administration.